From academia to business: development of novel therapeutics against HPV-associated cancer
Ended Project Grant Awarded Last action
- Award ID
- R44CA268137
- Recipient
-
Kovina Therapeutics Inc. UEI YBFLBP3NTM27
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $5,824,885
Award facts
- Assistance listing
- 93.393 Cancer Cause and Prevention Research
- Completion date
- Originally
- Place of performance
- Indiana, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | -$8,060 | |
| Amendment | $0 | |
| Amendment | $1,000,028 | |
| Amendment | $1,000,028 | |
| Amendment | $51,874 | |
| Amendment | $51,874 | |
| Amendment | $51,874 | |
| Amendment | -$38,639 | |
| Amendment | -$38,639 | |
| Amendment | -$38,639 | |
| Amendment | $948,296 | |
| Amendment | $948,296 | |
| Amendment | $948,296 | |
| Original award | $948,296 |
Show all 14
Quick answers
Who received award R44CA268137?
R44CA268137 was awarded to Kovina Therapeutics Inc. by National Cancer Institute (National Institutes of Health) on May 1, 2023.
How much is award R44CA268137 worth?
$5,824,885 has been obligated on R44CA268137.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award